As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
|Articles|July 1, 2004
- Volume 0 0
Guidelines Outline Hypertensive Therapy
Advertisement
New guidelines released by the National Kidney Foundation state that 20 million American adults with chronic kidney disease (CKD) should be considered in the highest risk group for developing cardiovascular disease. The guidelines, "Hypertension and Antihypertensive Agents in Chronic Kidney Disease," reported in the American Journal of Kidney Disease (May 2004), suggested that physicians can stabilize their kidney patients by reducing blood pressure levels to a maximum of 130/80 mm Hg.
The guidelines provide an integrated clinical action plan; key suggestions include:
- Blood pressure goal of 130/80 mm Hg is appropriate for all stages of CKD
- Protein in the urine, in addition to blood pressure, should be monitored to assess the response to antihypertensive agents
- Lifestyle modifications to lower blood pressure and reduce cardiovascular disease risk should be recommended to all CKD patients
Articles in this issue
over 22 years ago
Bloodstream Infection Risk Is Higher for Diabeticsover 22 years ago
Research Links Diabetes with Alzheimer'sover 22 years ago
Individuals with Chronic Pain Keep Quietover 22 years ago
Association Redesigns Web Siteover 22 years ago
Fibromyalgia Hits Individuals Differentlyover 22 years ago
Procedure May Relieve Agony of Spinal Cord Injuriesover 22 years ago
Europeans Are Slow to Seek Treatmentover 22 years ago
Intervention Curbs Asthma in Childrenover 22 years ago
Vaccine at Birth May Diminish Allergiesover 22 years ago
Asthma in Women Is Greater with Acetaminophen UseAdvertisement
Related to this article
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1C by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4
4
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
5